Clearmind Medicine Inc./$CMND
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Ticker
$CMND
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Vancouver, Canada
Employees
-
ISIN
CA1850534027
Website
CMND Metrics
BasicAdvanced
$4.6M
-
-$1.13
-1.31
-
Price and volume
Market cap
$4.6M
Beta
-1.31
52-week high
$1.30
52-week low
$0.80
Average daily volume
104K
Financial strength
Current ratio
1.745
Quick ratio
1.678
Total debt to equity
1.563
Interest coverage (TTM)
-111.11%
Profitability
EBITDA (TTM)
-5.85
Effective tax rate (TTM)
-4.31%
Management effectiveness
Return on assets (TTM)
-52.23%
Return on equity (TTM)
-139.17%
Valuation
Price to book
1.98
Price to tangible book (TTM)
2.08
Price to free cash flow (TTM)
-0.835
Free cash flow yield (TTM)
-119.74%
Free cash flow per share (TTM)
-106.45%
Growth
Earnings per share change (TTM)
-78.18%
3-year earnings per share growth (CAGR)
-80.26%
CMND News
AllArticlesVideos
Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
GlobeNewsWire·2 hours ago
Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
GlobeNewsWire·3 days ago
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
GlobeNewsWire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Clearmind Medicine Inc. stock?
Clearmind Medicine Inc. (CMND) has a market cap of $4.6M as of June 30, 2025.
What is the P/E ratio for Clearmind Medicine Inc. stock?
The price to earnings (P/E) ratio for Clearmind Medicine Inc. (CMND) stock is 0 as of June 30, 2025.
Does Clearmind Medicine Inc. stock pay dividends?
No, Clearmind Medicine Inc. (CMND) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Clearmind Medicine Inc. dividend payment date?
Clearmind Medicine Inc. (CMND) stock does not pay dividends to its shareholders.
What is the beta indicator for Clearmind Medicine Inc.?
Clearmind Medicine Inc. (CMND) has a beta rating of -1.31. This means that it has an inverse relation to market volatility.